Greg Walden actually said...

"Making sure our Government agencies have the tools necessary to ensure the safety and quality of the U.S. drug supply is a top priority for this committee."

"Historically, medicines intended for use in the United States have been produced here. However, over the past several years, more drug manufacturing has moved offshore."

"Recent recalls issued for a class of drugs known as angiotensin II receptor blockers, or ARBs, have led to public concern about the country's sourcing of finished drug products."

"I also want to make sure that, as policies move forward, we put the consumer first as we work on reducing emissions."